Target intelligence / Profile preview

MT-ND5 pseudogene 2 (MTND5P2)

Target
MTND5P2
Molecular classification
Pseudogene
01

Overview

**MT-ND5 pseudogene 2 (MTND5P2)** is a nuclear pseudogene corresponding to the mitochondrial NADH:ubiquinone oxidoreductase core subunit 5 gene (ND5)[6][8]. Unlike the functional mitochondrial ND5 gene, MTND5P2 is a non-coding sequence embedded in the nuclear genome and does not encode a functional protein. MTND5P2 is classified as a pseudogene that likely arose from nuclear integration of mitochondrial DNA (NUMT) and harbors mutations and truncations that prevent translation into a functional protein[6][7][8]. There is no evidence in the scientific literature that MTND5P2 plays a direct role in biological pathways, disease, or drug targeting. **Summary of findings:** - MT-ND5 pseudogene 2 is a **pseudogene** and not a conventional drug target or functional protein[6][8]. - It does **not encode an enzyme, receptor, or transporter**, and there is no evidence for its role in signaling or cellular function[6][7][8]. - No drugs, biomarkers, or disease roles are directly associated with this gene. Please note that this distinguishes MTND5P2 from the functional mitochondrial gene MT-ND5, which is involved in mitochondrial respiratory complex I and is important in energy production and disease[1][3][7].

Other names
MTND5P2mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 pseudogene 2MT-ND5P2NADH dehydrogenase 5 pseudogene 2
02

Biological functions

Other (does not have a direct biological function; does not produce a functional protein)
03

Disease associations

Other (no direct disease association; pseudogenes can sometimes act as sources of regulatory RNA, but there is no evidence for MTND5P2 involvement in disease)

Beyond the preview

Go deeper on MT-ND5 pseudogene 2 (MTND5P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND5 pseudogene 2 (MTND5P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call